4 September 2017 - Drug prices in the U.K., already among the lowest in the developed world, may drop lower still.
The British public health care system has adopted new limits on how much it spends on certain medicines, prompting pharmaceutical companies to sue in a bid to stop the initiative.
At a time when U.S. President Donald Trump has pledged to bring down the cost of medicine and health care in the U.S., the U.K.’s experience can offer lessons as well as cautionary tales.